Gastroenterology
Volume 137, Issue 4 , Pages 1229-1237 , October 2009

Endoscopist-Directed Administration of Propofol: A Worldwide Safety Experience

  • Douglas K. Rex

      Affiliations

    • Division of Gastroenterology/Hepatology, Indiana University Medical Center, Indianapolis, Indiana
    • Corresponding Author InformationReprint requests Address requests for reprints to: Douglas K. Rex, MD, FACP, FACG, Indiana University Medical Center, #4100, 550 North University Boulevard, Indianapolis, Indiana 46202. fax: (317) 274-5449
    • ,
  • Viju P. Deenadayalu

      Affiliations

    • Division of Gastroenterology/Hepatology, Indiana University Medical Center, Indianapolis, Indiana
    • ,
  • Emely Eid

      Affiliations

    • Division of Gastroenterology/Hepatology, Indiana University Medical Center, Indianapolis, Indiana
    • ,
  • Thomas F. Imperiale

      Affiliations

    • Division of Gastroenterology/Hepatology, Indiana University Medical Center, Indianapolis, Indiana
    • Regenstrief Institute, Inc, Indianapolis, Indiana
    • ,
  • John A. Walker

      Affiliations

    • Gastroenterology Consultants, P.C., Medford, Oregon
    • ,
  • Kuldip Sandhu

      Affiliations

    • Capitol Gastroenterology Consultants Medical Group, Inc, Carmichael, California
    • ,
  • Anthony C. Clarke

      Affiliations

    • Capitol Gastroenterology Consultants Medical Group, Inc, Carmichael, California
    • ,
  • Lybus C. Hillman

      Affiliations

    • Mugga Wara and Brindabella Endoscopy Centres, Brindabella Specialist Centre, Garran, ACT, Australia
    • ,
  • Akira Horiuchi

      Affiliations

    • Department of Gastroenterology, Showa Inan General Hospital, Komagene, Japan
    • ,
  • Lawrence B. Cohen

      Affiliations

    • Division of Gastroenterology, Department of Medicine, Mt Sinai Medical Center, New York, New York
    • ,
  • Ludwig T. Heuss

      Affiliations

    • University Hospital of Basel, Department of Gastroenterology, Basel, Switzerland
    • ,
  • Shajan Peter

      Affiliations

    • University Hospital of Basel, Department of Gastroenterology, Basel, Switzerland
    • ,
  • Christoph Beglinger

      Affiliations

    • University Hospital of Basel, Department of Gastroenterology, Basel, Switzerland
    • ,
  • James A. Sinnott

      Affiliations

    • Valdosta Medical Clinic, Valdosta, Georgia
    • ,
  • Thomas Welton

      Affiliations

    • Stormont-Vail HealthCare, Topeka, Kansas
    • ,
  • Magdy Rofail

      Affiliations

    • Reid Memorial Hospital, Richmond, Indiana
    • ,
  • Iyad Subei

      Affiliations

    • Jeddah Center for Liver and Digestive Diseases, Erfan & Badego General Hospital, Jeddah, Saudi Arabia
    • ,
  • Rodger Sleven

      Affiliations

    • The Oregon Clinic, West Hills Gastroenterology, Portland, Oregon
    • ,
  • Paul Jordan

      Affiliations

    • Section of Gastroenterology, Department of Medicine, LSU Health Sciences Center, Shreveport, Louisiana
    • ,
  • John Goff

      Affiliations

    • Rocky Mountain Gastroenterology Associates, Lakewood, Colorado
    • ,
  • Patrick D. Gerstenberger

      Affiliations

    • Digestive Health Associates, Durango, Colorado
    • ,
  • Harold Munnings

      Affiliations

    • The Centre for Digestive Health, Nassau, Bahamas
    • ,
  • Martin Tagle

      Affiliations

    • Clinica Anglo Americana, Lima, Peru
    • ,
  • Brian W. Sipe

      Affiliations

    • Northside Gastroenterology, Indianapolis, Indiana
    • ,
  • Till Wehrmann

      Affiliations

    • Deutsche Klinik Für Diagnostik, Wiesbaden, Germany
    • ,
  • Jack A. Di Palma

      Affiliations

    • Division of Gastroenterology, University of South Alabama College of Medicine, Mobile, Alabama
    • ,
  • Kaitlin E. Occhipinti

      Affiliations

    • Division of Gastroenterology, University of South Alabama College of Medicine, Mobile, Alabama
    • ,
  • Egidio Barbi

      Affiliations

    • Clinica Pediatrica, University of Trieste, Italy
    • ,
  • Andrea Riphaus

      Affiliations

    • Department of Internal Medicine I, Klinikum Region Hannover Siloah, Hannover, Germany
    • ,
  • Stephen T. Amann

      Affiliations

    • North Mississippi Medical Center, Tupelo, Mississippi
    • ,
  • Gen Tohda

      Affiliations

    • Department of Gastrointestinal Endoscopy, Fukui Kosei Hospital, Fukui, Japan
    • ,
  • Timothy McClellan

      Affiliations

    • Wichita Falls Endoscopy Center, Wichita Falls, Texas
    • ,
  • Charles Thueson

      Affiliations

    • Wichita Falls Endoscopy Center, Wichita Falls, Texas
    • ,
  • John Morse

      Affiliations

    • Stanton Medical Centre, Yellowknife, Northwest Territories, Canada
    • ,
  • Nizam Meah

      Affiliations

    • Your GI Center, Lake Jackson/Pearland, Texas

Received 19 December 2008 ,Accepted 11 June 2009.

References 

  1. Cohen LB, Wecsler JS, Gaetano JN, et al. Endoscopic sedation in the United States: results from a nationwide survey. Am J Gastroenterol. 2006;101:967–974
  2. Lichtenstein DR, Jagannath S, Baron TH, et al. Sedation and anesthesia in GI endoscopy. Gastrointest Endosc. 2008;68:205–216
  3. American Society for Gastrointestinal Endoscopy. Training guideline for use of propofol in gastrointestinal endoscopy. Gastrointest Endosc. 2004;60:167–172
  4. Kazama T, Takeuchi K, Ikeda K, et al. Optimal propofol plasma concentration during upper gastrointestinal endoscopy in young, middle-aged, and elderly patients. Anesthesiology. 2000;93:662–669
  5. Vargo JJ, Zuccaro G, Dumot JA, et al. Gastroenterologist-administered propofol versus meperidine and midazolam for advanced upper endoscopy: a prospective, randomized trial. Gastroenterology. 2002;123:8–16
  6. Kulling D, Orlandi M, Inauen W. Propofol sedation during endoscopic procedures: how much staff and monitoring are necessary?. Gastrointest Endosc. 2007;66:443–449
  7. Rex DK, Heuss LT, Walker JA, Qi R. Trained registered nurses/endoscopy teams can administer propofol safely for endoscopy. Gastroenterology. 2005;129:1384–1391
  8. Clarke A, Chiragakis L, Hillman LC, Kaye GL. Sedation for endoscopy: the safe use of propofol by general practitioner sedationists. Med J Aust. 2002;176:158–161
  9. Kongkam P, Pornphisarn B, Rerknimitr R. Non-anesthetist administered propofol for ERCP; efficacy, safety profile and side effect: a prospective randomized trial. [abstract] Gastrointest Endosc. 2004;59:AB127
  10. Gonzalez-Huix F, Aldeguer X, Fort E, et al. Sedation without anesthesiologist in 5250 endoscopic procedures: midazolam vs. midazolam + dolantine vs. propofol. [abstract] Gastrointest Endosc. 2004;59:AB133
  11. Kulling D, Rothenbuhler R, Inauen W. Safety of nonanesthetist sedation with propofol for outpatient colonoscopy and esophagogastroduodenoscopy. Endoscopy. 2003;35:679–682
  12. Cohen LB, Hightower CD, Wood DA, Miller KM, Aisenberg J. Moderate level sedation during endoscopy: a prospective study using low-dose propofol, meperidine/fentanyl, and midazolam. Gastrointest Endosc. 2004;59:795–803
  13. Heuss LT, Froehlich F, Beglinger C. Changing patterns of sedation and monitoring practice during endoscopy: results of a nationwide survey in Switzerland. Endoscopy. 2005;37:161–166
  14. Vargo JJ, Holub JL, Faigel DO, Lieberman DA, Eisen GM. Risk factors for cardiopulmonary events during propofol-mediated upper endoscopy and colonoscopy. Aliment Pharmacol Ther. 2006;24:955–963
  15. Koshy G, Nair S, Norkus E, et al. Propofol versus midazolam and meperidine for conscious sedation in GI endoscopy. Am J Gastrenterol. 2000;95:1476–1479
  16. Yusoff IF, Raymond G, Sahai AV. Endoscopist administered propofol for upper-GI EUS is safe and effective: a prospective study in 500 patients. Gastrointest Endosc. 2004;60:356–360
  17. Sinnott J, Fricker E, Rogers A. Propofol/meperidine versus midazolam/meperidine: a one year comparison in a community based surgery center. Am J Gastroenterol. 2004;99(suppl):S303–S304
  18. Meah N, Parikh PB. Efficacy and safety of nurse-administered propofol as an adjunctive agent of conscious sedation in private non-academic gastroenterology practice setting. Am J Gastroenterol. 2004;99(suppl):S313
  19. Riphaus A, Stergiou N, Wehrmann T. Sedation with propofol for routine ERCP in high-risk octogenarians: a randomized, controlled study. Am J Gastroenterol. 2005;100:1957–1963
  20. Chen WX, Lin HJ, Zhang WF, et al. Sedation and safety of propofol for therapeutic endoscopic retrograde cholangiopancreatography. Hepatobiliary Pancreat Dis Int. 2005;4:437–440
  21. Tohda G, Higashi S, Wakahara S, Morikawa M, Sakumoto H, Kane T. Propofol sedation during endoscopic procedures: safe and effective administration by registered nurses supervised by endoscopists. Endoscopy. 2006;38:360–367
  22. Tohda G, Higashi S, Sakumoto H, Sumiyoshi K, Kane T. Efficacy and safety of nurse-administered propofol sedation during emergency upper endoscopy for gastrointestinal bleeding: a prospective study. Endoscopy. 2006;38:684–689
  23. Barbi E, Petaros P, Badina L, et al. Deep sedation with propofol for upper gastrointestinal endoscopy in children, administered by specially trained pediatricians: a prospective case series with emphasis on side effects. Endoscopy. 2006;38:368–375
  24. Peter S, Wunderlich P, Beglinger C, Heuss LT. Is nurse administered propofol sedation (NAPS) safe for endoscopies in a gastroenterologist ambulatory practice?. [abstract] Gastroenterology. 2007;132:A129
  25. Sipe BW, Scheidler M, Baluyut A, Wright B. A prospective safety study of a low-dose propofol sedation protocol for colonoscopy. Clin Gastroenterol Hepatol. 2007;5:563–566
  26. Tagle M, Siu H, Ramos M. Propofol in combination with meperidine and midazolam in colonoscopy and upper endoscopy: first prospective study in private practice in Peru. Rev Gastroenterol Peru. 2007;27:367–373
  27. Cohen LB, Dubovsky AN, Aisenberg J, Miller KM. Propofol for endoscopic sedation: a protocol for safe and effective administration by the gastroenterologist. Gastrointest Endosc. 2003;58:725–732
  28. Wehrmann T, Grotkamp J, Stergiou N, et al. Electroencephalogram monitoring facilitates sedation with propofol for routine ERCP: a randomized, controlled trial. Gastrointest Endosc. 2002;56:817–824
  29. Wehrmann T, Kokabpick S, Lembcke B, et al. Efficacy and safety of intravenous propofol sedation during routine ERCP: a prospective, controlled study. Gastrointest Endosc. 1999;49:677–683
  30. Carlsson U, Grattidge P. Sedation for upper gastrointestinal endoscopy: a comparative study of propofol and midazolam. Endoscopy. 1995;27:240–243
  31. Saenz-Lopez S, Rodriguez Munoz S, Rodriguez-Alcalde D, et al. Endoscopist controlled administration of propofol: an effective and safe method of sedation in endoscopic procedures. Rev Esp Enferm Dig. 2006;98:25–35
  32. Morse JW, Fowler SA, Morse AL. Endoscopist-administered propofol: a retrospective safety study. Can J Gastroenterol. 2008;22:617–620
  33. Vargo JJ. Propofol: a gastroenterologist's perspective. Gastrointest Endosc Clin North Am. 2004;14:313–323
  34. Sipe BW, Rex DK, Latinovich D, et al. Propofol versus midazolam/meperidine for outpatient colonoscopy: administration by nurses supervised by endoscopists. Gastrointest Endosc. 2002;55:815–825
  35. Ulmer BJ, Hansen JJ, Overley CA, et al. Propofol versus midazolam/fentanyl for outpatient colonoscopy: administration by nurses supervised by endoscopists. Clin Gastroenterol Hepatol. 2003;1:425–432
  36. Faulx AL, Vela S, Das A, et al. A changing landscape of practice patterns regarding unsedated endoscopy and propofol use: a national survey. [abstract] Gastrointest Endosc. 2004;59:AB131
  37. Dewitt J, Leblanc J, McHenry L, et al. Registered nurse-administered propofol sedation (RNAPS) versus midazolam and meperidine (MM) for endoscopic ultrasound (EUS): a prospective, randomized trial. [abstract] Gastrointest Endosc. 2003;57:AB78
  38. Walker J, McIntyre R, Schleinitz P, et al. Nurse-administered propofol sedation without anesthesia specialists in 9152 endoscopic cases in an ambulatory surgery center. Am J Gastroenterol. 2003;98:1744–1750
  39. Heuss LT, Schnieper P, Drewe J, Pflimlin E, Beglinger C. Risk stratification and safe administration of propofol by registered nurses supervised by the gastroenterologist: a prospective observational study of more than 2000 cases. Gastrointest Endosc. 2003;57:664–671
  40. Rex DK, Overley C, Kinser K, et al. Safety of propofol administered by registered nurses with gastroenterologist supervision in 2000 endoscopic cases. Am J Gastroenterol. 2002;97:1159–1163
  41. Chen SC, Rex DK. An initial investigation of bispectral monitoring as an adjunct to nurse-administered propofol sedation for colonoscopy. Am J Gastroenterol. 2004;99:1081–1086
  42. Drake LM, Chen SC, Rex DK. Efficacy of bispectral monitoring as an adjunct to nurse-administered propofol sedation for colonoscopy: a randomized controlled trial. Am J Gastroenterol. 2006;101:2003–2007
  43. Fatima H, DeWitt J, LeBlanc J, Sherman S, McGreevy K, Imperiale TF. Nurse-administered propofol sedation for upper endoscopic ultrasonography. Am J Gastroenterol. 2008;103:1649–1656
  44. VanNatta ME, Rex DK. Propofol alone titrated to deep sedation versus propofol in combination with opioids and/or benzodiazepines and titrated to moderate sedation for colonoscopy. Am J Gastroenterol. 2006;101:2209–2217
  45. Heuss LT, Drewe J, Schnieper P, Tapparelli CB, Pflimlin E, Beglinger C. Patient-controlled versus nurse-administered sedation with propofol during colonoscopy (A prospective randomized trial). Am J Gastroenterol. 2004;99:511–518
  46. Weston BR, Chadalawada V, Chalasani N, et al. Nurse-administered propofol versus midazolam and meperidine for upper endoscopy in cirrhotic patients. Am J Gastroenterol. 2003;98:2440–2447
  47. Chen S, Rex D. Review article: registered nurse administered propofol sedation for endoscopy. Aliment Pharmacol Ther. 2004;19:147–155
  48. Rex DK. Review article: moderate sedation for endoscopy: sedation regimens for non-anaesthesiologists. Aliment Pharmacol Ther. 2006;24:163–171
  49. Qadeer MA, Vargo JJ, Khandwala F, Lopez R, Zuccaro G. Propofol versus traditional sedative agents for gastrointestinal endoscopy: a meta-analysis. Clin Gastroenterol Hepatol. 2005;3:1049–1056
  50. DeWitt JM. Bispectral index monitoring for nurse-administered propofol sedation during upper endoscopic ultrasound: a prospective, randomized controlled trial. Dig Dis Sci. 2008;53:2739–2745
  51. Vargo JJ, Zuccaro G, Dumot JA, Shay SS, Conwell DL, Morrow JB. Gastroenterologist-administered propofol for therapeutic upper endoscopy with graphic assessment of respiratory activity: a case series. Gastrointest Endosc. 2000;52:250–255
  52. Pambianco DJ, Whitten CJ, Moerman A, Struys MM, Martin JF. An assessment of computer-assisted personalized sedation: a sedation delivery system to administer propofol for gastrointestinal endoscopy. Gastrointest Endosc. 2008;68:542–547
  53. Aisenberg J, Brill JV, Ladabaum U, Cohen LB. Sedation for gastrointestinal endoscopy: new practices, new economics. Am J Gastroenterol. 2005;100:996–1000
  54. AANA-ASA joint statement regarding propofol administration. http://www.asahq.org/Accessed August 15, 2008
  55. ASA House of Delegates statement on safe use of propofol. http://www.asahq.org/Accessed August 15, 2008
  56. ASA House of Delegates Statement on granting privileges to nonanesthesiologist practitioners for personally administering deep sedation or supervising deep sedation by individuals who are not anesthesia professionals. http://www.asahq.org/Accessed August 15, 2008
  57. Gallivan S. Mathematical methods to assist with hospital operation and planning. Clin Invest Med. 2005;28:326–330
  58. Sharma VK, Nguyen CC, Crowell MD, Lieberman DA, de Garmo P, Fleischer DE. A national study of cardiopulmonary unplanned events after GI endoscopy. Gastrointest Endosc. 2007;66:27–34
  59. Arrowsmith J, Gerstman BB, Fleischer DE, et al. Results from the American Society for Gastrointestinal Endoscopy/U.S. Food and Drug Administration collaborative study on complication rates and drug use during gastrointestinal endoscopy. Gastrointest Endosc. 1991;37:421–427
  60. Daneshmend TK, Bell GD, Logan RF. Sedation for upper gastrointestinal endoscopy: results of a nationwide survey. Gut. 1991;32:12–15
  61. Quine MA, Bell GD, McCloy RF, Charlton JE, Devlin HB, Hopkins A. Prospective audit of upper gastrointestinal endoscopy in two regions of England: safety, staffing, and sedation methods. Gut. 1995;36:462–467
  62. Thompson AM, Wright DJ, Murray W, Ritchie GL, Burton HD, Stonebridge PA. Analysis of 153 deaths after upper gastrointestinal endoscopy: room for improvement?. Surg Endosc. 2004;18:22–25
  63. Froehlich F, Gonvers J, Fried M. Conscious sedation, clinically relevant complications and monitoring of endoscopy: results of a nationwide survey in Switzerland. Endoscopy. 1994;26:231–234
  64. Farrow SC, Fowkes FG, Lunn JN, Robertson IB, Samuel P. Epidemiology in anaesthesia; II: factors affecting mortality in hospital. Br J Anaesth. 1982;54:811–817
  65. Eichhorn JH. Prevention of intraoperative anesthesia accidents and related severe injury through safety monitoring. Anesthesiology. 1989;70:572–577
  66. Warner MA, Shields SE, Chute CG. Major morbidity and mortality within 1 month of ambulatory surgery and anesthesia. JAMA. 1993;270:1437–1441
  67. Spence AA. The lessons of CEPOD. Br J Anaesth. 1988;60:753–754
  68. Lunn JN, Devlin HB. Lessons from the confidential enquiry into perioperative deaths in three NHS regions. Lancet. 1987;2:1384–1386
  69. Lienhart A, Auroy Y, Pequignot F, et al. Survey of anesthesia-related mortality in France. Anesthesiology. 2006;105:1087–1097
  70. Kawashima Y, Takahashi S, Suzuki M, et al. Anesthesia-related mortality and morbidity over a 5-year period in 2,363,038 patients in Japan. Acta Anaesthesiol Scand. 2003;47:809–817
  71. Newland MC, Ellis SJ, Lydiatt CA, et al. Anesthetic-related cardiac arrest and its mortality: a report covering 72,959 anesthetics over 10 years from a US teaching hospital. Anesthesiology. 2002;97:108–115
  72. Gibbs N, Rodoreda P. Anaesthetic mortality rates in Western Australia 1980–2002. Anaesth Intensive Care. 2005;33:616–622
  73. Arbous MS, Grobbee DE, van Kleef JW, et al. Mortality associated with anaesthesia: a qualitative analysis to identify risk factors. Anaesthesia. 2001;56:1141–1153
  74. Lagasse RS. Anesthesia safety: model or myth? A review of the published literature and analysis of current original data. Anesthesiology. 2002;97:1609–1617
  75. Cohen MM, Duncan PG, Tate RB. Does anesthesia contribute to operative mortality?. JAMA. 1988;260:2859–2863
  76. Chapman RH, Stone PW, Sandberg EA, Bell C, Neumann PJ. A comprehensive league table of cost-utility ratios and a sub-table of “panel-worthy” studies. Med Decis Making. 2000;20:451–467
  77. Lubarsky DA, Candiotti K, Harris E. Understanding modes of moderate sedation during gastrointestinal procedures: a current review of the literature. J Clin Anesth. 2007;19:397–404
  78. Bhananker SM, Posner KL, Cheney FW, Caplan RA, Lee LA, Domino KB. Injury and liability associated with monitored anesthesia care: a closed claims analysis. Anesthesiology. 2006;104:228–234
  79. Cohen LB, Delegge MH, Aisenberg J, et al. AGA institute review of endoscopic sedation. Gastroenterology. 2007;133:675–701
  80. Byrne MF, Chiba N, Singh H, Sadowski DC. Propofol use for sedation during endoscopy in adults: a Canadian Association of Gastroenterology position statement. Can J Gastroenterol. 2008;22:457–459
  81. Knape JT, Adriaensen H, van Aken H, et al. Guidelines for sedation and/or analgesia by non-anaesthesiology doctors. Eur J Anaesthesiol. 2007;24:563–567

 To view this article's video abstract, go to the AGA's YouTube Channel.

 This article has an accompanying continuing medical education activity on page 1518. Learning Objective: Upon completion of reading this article, successful learners will be able to identify facts about propofol important for its use by non-anesthesiologists.

 Conflicts of interest The authors disclose the following: J.A. Walker is CEO of Dr. NAPS, LLC; T. Wehrmann received speaker's fees and research support from Fresenius-Kabi, Germany; A. Riphaus received speaker's fees from Fresenius-Kabi, Falk Pharma and Nycomed, Germany, and research support from Fresenius-Kabi, Germany. The remaining authors disclose no conflicts.

 Douglas K. Rex had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.

PII: S0016-5085(09)00999-8

doi: 10.1053/j.gastro.2009.06.042

Gastroenterology
Volume 137, Issue 4 , Pages 1229-1237 , October 2009

Article Tools